Navamedic ASA Navamedic ASA

Navamedic ASA

NAVA

Rank in Stocks #25095
Navamedic ASA, an Oslo, Norway-based pharmaceutical firm established in 2002... Navamedic ASA, an Oslo, Norway-based pharmaceutical firm established in 2002 and formerly known as Glucomed AS until its name change in 2004, operates across Northern Europe. The company is actively involved in the entire lifecycle of pharmaceutical and related goods, from development and manufacturing to their commercialization and distribution. Its comprehensive portfolio encompasses a diverse range of products, including prescribed and over-the-counter medications, specialized medical nutrition, medical devices, dietary supplements, and cosmetic items. A significant portion of its offerings is dedicated to medical nutrition, formulated to address various metabolic disorders such as phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders. These nutritional solutions also cater to conditions like glycogen storage diseases, renal diseases, fat metabolism issues, malnutrition, and support for ketogenic diets. Furthermore, Navamedic features a consumer health division providing non-prescription drugs and wellness products for common ailments including pain relief, coughs, colds, gastrointestinal issues, and women's health, primarily distributed through pharmacies and drugstores. The company also supplies specialty pharmaceuticals targeting specific therapeutic areas such as dermatology, wound care, women's health, urology, and obesity. Completing its product line are branded generics, notably in cardiology and antibiotics. Its widespread distribution network ensures products reach hospitals, individual patients, and retail pharmacies throughout its operational regions.
Share Price
$1.13
Last synced: 2026-11-13
Market Cap
$27.06M
Change (1 day)
3.22%
Change (1 year)
-45.87%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Navamedic ASA (NAVA)
EPS as of September 2026 TTM: $-0.11
According to Navamedic ASA's latest financial reports, its current EPS (TTM) is $-0.11. At the end of 2025 the company had an EPS of $-0.10, a decrease compared to its 2024 EPS of $0.01.
EPS history for Navamedic ASA from 2003 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.11 7.60%
2025 $-0.10 -1,617.19%
2024 $0.01 -65.78%
2023 $0.02 -89.56%
2022 $0.18 4,065.12%
2021 0.00 -103.26%
2020 $-0.13 -17.86%
2019 $-0.16 -304.19%
2018 $0.08 -145.18%
2017 $-0.17 44.68%
2016 $-0.12 -14.18%
2015 $-0.14 1,211.21%
2014 $-0.01 -56.68%
2013 $-0.02 -65.60%
2012 $-0.07 -54.76%
2011 $-0.16 -37.45%
2010 $-0.25 -186.18%
2009 $0.29 -292.29%
2008 $-0.15 62.70%
2007 $-0.09 -55.84%
2006 $-0.21 32.11%
2005 $-0.16 -182.76%
2004 $0.19 1,081.21%
2003 $0.02 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$39.05 -36,391.82%
US
$17.99 -16,819.33%
US
$7.77 -7,321.19%
US
$17.99 -16,819.33%
US
$0.04 -138.75%
AU

Questions about Navamedic ASA's earnings per share (EPS)

What is Navamedic ASA's earnings per share (EPS)?

Navamedic ASA's earnings per share (EPS) over the last twelve months is $-0.11, as of Sep 2026.

What was Navamedic ASA's earnings per share (EPS) in 2025?

In 2025, Navamedic ASA's earnings per share (EPS) was $-0.10, compared with $0.01 in 2024.

How has Navamedic ASA's earnings per share (EPS) changed since 2020?

From 2020 to 2025, Navamedic ASA's earnings per share (EPS) was highest in 2022 ($0.18) and lowest in 2020 ($-0.13).

How does Navamedic ASA's earnings per share (EPS) compare with similar companies?

Navamedic ASA's earnings per share (EPS) ($-0.11) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.